Sandoz Group AG (OTCMKTS:SDZNY - Get Free Report)'s stock price reached a new 52-week high on Thursday . The stock traded as high as $52.21 and last traded at $51.95, with a volume of 182726 shares trading hands. The stock had previously closed at $51.12.
Analyst Ratings Changes
Separately, Royal Bank of Canada upgraded shares of Sandoz Group from a "hold" rating to a "moderate buy" rating in a report on Friday, May 2nd.
Check Out Our Latest Research Report on SDZNY
Sandoz Group Trading Up 0.1%
The company's fifty day moving average is $44.25 and its two-hundred day moving average is $44.16.
About Sandoz Group
(
Get Free Report)
Sandoz Group AG develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide. The company covers therapeutic areas, including cardiovascular, central nervous system, oncology, infectious diseases, pain and respiratory, diabetes, immunology, endocrinology, hematology, and ophthalmology, as well as bone disease.
Further Reading
Before you consider Sandoz Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sandoz Group wasn't on the list.
While Sandoz Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
